Catherine R Lavaro, NP

Medicare standing: Clear; Enrolled, allowed to bill and order, not excluded
Plans that list them: Not verified; Not the same as out of network.
Office: 1
Since medical school: 4 years; Graduated 2022

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Catherine R Lavaro’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Drugs they prescribed that Part D paid

$47,785

Pharmacies billed $47,785 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

122 generic and fewer than 11 brand-name prescriptions · $47,785 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Posaconazole	23	$23,661	$1,029
Valganciclovir	15	$3,645	$243
Pantoprazole	22	$99	$4
Rosuvastatin	11	$52	$5

Year by year

Sort by

Part D prescribing by year

2024	127	11	None	None	$47,785
2023	161	13	None	None	$143,930

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 5 drugs

Sort by

Part D drugs prescribed in 2023

Posaconazole	18	$59,397	$3,300
Valganciclovir	17	$10,513	$618
Sulfamethoxazole-Trimethoprim	12	$160	$13
Pantoprazole	19	$156	$8
Rosuvastatin	16	$83	$5

Professional record

NPI: 1427785609
Licence: CA 95022066
Group: Stanford Health Care
Gender: Female

More record details

Sole proprietor: Yes
Taxonomy: Nurse practitioner (363L00000X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2022-08-06
NPI last updated: 2023-04-11
NPI record certified: 2023-04-11

This is when the NPI record was last certified, not a medical board exam.